[Tegafur.uracil for treatment of colorectal cancer].
Fujii
Masashi
M
Department of Surgery, Nihon University Surugadai Hospital.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D019008:Drug Resistance, Neoplasm; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D005641:Tegafur / Q000008:administration & dosage / Q000494:pharmacology; D016896:Treatment Outcome; D014407:Tumor Cells, Cultured; D014498:Uracil / Q000008:administration & dosage / Q000494:pharmacology
D005641:Tegafur; D014498:Uracil; D002955:Leucovorin